Thus, combining radiotherapy and anti-CD25/CTLA-4 monoclonal antibody resulted in decreased Tregs and enhanced anti-tumor immunity, suppressed the tumor growth, and improved the overall survival (Table 4) [306]. Here, CTLA4 is linked to neoplasm.